X Ray Absorption Near Edge Spectroscopy (XANES) Shows Abnormal Iron Oxidation State in Alzheimer’s Hippocampi

Dean Tran, Phillip DiGiacomo, Jeffrey Nirschl, Nicholas P. Edwards, Sharon Bone, Samuel M. Webb, Marios Georgiadis, Michael ZeinehAlzheimer 2024 · DOI

TL;DR

This study reveals that the hippocampus in Alzheimer's Disease (AD) patients shows an elevated proportion of ferrous iron (Fe²⁺) compared to controls. This finding is significant because Fe²⁺ is known to contribute to oxidative stress, a key factor in AD pathology. The research also highlights that sample preparation, specifically thawing, can alter the measured iron oxidation state, suggesting that in-situ measurements might be crucial for accurate assessment.

What Problem Does This Paper Address?

Alzheimer's Disease (AD) is a devastating neurodegenerative disorder, and recent research points to the roles of iron dysregulation and neuroinflammation in its progression. Specifically, ferrous iron (Fe²⁺) is implicated in causing oxidative stress and cellular damage, which are hallmarks of AD. However, it has been unclear whether Fe²⁺ is elevated in the hippocampus, a brain region critically affected by AD, and to what extent. This paper aims to quantify the iron oxidation state in human hippocampi from individuals with varying stages of AD and compare it to healthy controls, addressing the gap in understanding iron's role in AD pathology at the oxidation state level.

Methods

The researchers employed X-ray Fluorescence Imaging (XFI) to identify regions of interest (ROIs) with high iron concentration within frozen human brain hippocampi. Following the identification of these ROIs, X-ray Absorption Near Edge Structure (XANES) spectroscopy was used to determine the relative proportions of Fe²⁺ and Fe³⁺ in the iron deposits. This technique works by analyzing the subtle changes in X-ray absorption near the iron K-edge, which are sensitive to the iron's oxidation state. To account for potential artifacts from sample handling, three hippocampal specimens were scanned while kept frozen, and then re-scanned after thawing. Statistical analyses, including Fischer's exact test and a zero/one-inflated beta (ZOIB) regression model, were used to assess the association between AD stage and Fe²⁺ levels, with the ZOIB model being particularly suited for bounded measures with excess zeros. A Wilcoxon signed-rank test was used to compare Fe²⁺ proportions in frozen versus thawed samples.

Datasets

The study utilized 22 fresh-frozen human brain hippocampi obtained from the Stanford Alzheimer's Disease Research Center. These samples were categorized into three groups: high AD (n=13), low AD (n=7), and non-AD controls (n=2).

Key Insights and Ideas

  • Iron's Oxidative Role in AD: The study provides direct evidence that the hippocampus, a key brain region affected by AD, exhibits an altered iron oxidation state, with a higher proportion of the pro-oxidant Fe²⁺. This strengthens the link between iron dysregulation and AD pathogenesis.
  • Hippocampal Vulnerability: The focus on the hippocampus is crucial, as this region is heavily involved in memory and cognition, and its degeneration is central to AD symptoms.
  • Sample Preparation Matters: The finding that thawing iron deposits significantly reduces the measured Fe²⁺ proportion is a critical methodological insight. It suggests that the dynamic nature of iron oxidation states and their sensitivity to environmental changes (like temperature) must be carefully considered in future research. This implies that in-situ or cryo-preserved measurements might be essential for capturing the true in-vivo state.
  • Gradual Increase in Fe²⁺: The results indicate a dose-dependent increase in Fe²⁺, with both low and high AD stages showing significantly higher proportions compared to controls, suggesting a progressive alteration in iron metabolism or handling as the disease advances.

Key Results

  • A statistically significant increase in Fe²⁺ was observed in AD specimens compared to controls (p = 0.007).
  • The ZOIB regression model revealed that both low AD (z = 9.10, p < 0.001) and high AD (z = 3.36, p = 0.001) hippocampi exhibited a significantly higher proportion of Fe²⁺ compared to controls.
  • Thawed iron deposits showed a statistically significant lower proportion of Fe²⁺ compared to their frozen state (p = 0.0145).

Limitations and Future Work

The authors acknowledge that the number of control samples (n=2) is relatively small, which could limit the generalizability of the findings. The study also highlights the impact of sample thawing on iron oxidation state measurements. Future work could focus on:

  • Investigating the mechanisms driving the increase in Fe²⁺ in AD hippocampi, such as altered iron transport, storage, or metabolism.
  • Exploring the correlation between Fe²⁺ levels and other AD biomarkers or cognitive decline.
  • Developing and applying techniques that minimize or account for sample preparation artifacts to obtain more accurate in-vivo measurements of iron oxidation states in neurodegenerative diseases.
  • Expanding the study to include a larger cohort of control samples and potentially other brain regions affected by AD.

Summary updated

Abstract

We found increased Fe<sup>2+</sup> in thawed AD hippocampi compared to controls. Additionally, the thawing of frozen iron deposits resulted in a decrease of measured Fe<sup>2+</sup>. These findings may suggest actual differences are even higher between iron oxidation state in AD hippocampi versus controls.
BibTeX
@inproceedings{tran2024x,
  author = {Dean Tran and Phillip DiGiacomo and Jeffrey Nirschl and Nicholas P. Edwards and Sharon Bone and Samuel M. Webb and Marios Georgiadis and Michael Zeineh},
  title = {{X Ray Absorption Near Edge Spectroscopy (XANES) Shows Abnormal Iron Oxidation State in Alzheimer’s Hippocampi}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.088089},
}
Figure